- Home
- BGI vs POM Comparison
BGI vs POM Comparison
Compare BGI & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BGI | POM |
|---|---|---|
| Founded | 1879 | 2015 |
| Country | Canada | China |
| Employees | N/A | N/A |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 13.5M |
| IPO Year | 2002 | N/A |
Fundamental Metrics
Financial Performance| Metric | BGI | POM |
|---|---|---|
| Price | $0.63 | $0.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.5K | ★ 18.2M |
| Earning Date | 12-05-2025 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.56 | $0.06 |
| 52 Week High | $1.57 | $6.43 |
Technical Indicators
Market Signals| Indicator | BGI | POM |
|---|---|---|
| Relative Strength Index (RSI) | 38.98 | 36.38 |
| Support Level | N/A | $0.06 |
| Resistance Level | $0.71 | $0.43 |
| Average True Range (ATR) | 0.03 | 0.04 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 20.02 | 19.57 |
Price Performance
Historical ComparisonAbout BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.